A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors
Clinical trial NCT03295942 · TERMINATED
Trial details
- NCT number
- NCT03295942
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-12
- Primary completion
- 2019-07-04
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.